Evidence map›Paper›PMID 22392370›Full record

ReviewCurrent cardiology reports2012

The role of renal denervation in the treatment of heart failure.

Paul A Sobotka, Henry Krum, Michael Böhm, Darrel P Francis, Markus P Schlaich

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01639378 phase3unknown statusnot on this map

Impact of Renal Artery Denervation in Patients With Chronic Heart Failure Compared With Sham Procedure

TypeinterventionalSponsorImperial College LondonRan2012Enrolled76ConditionsChronic Systolic Heart FailureArmsRenal Denervation
NCT01840059 phase2completednot on this mapstarted 2013, after this paper: background citation

A Randomised Controlled Trial Investigating the Effect of Transcatheter Renal Sympathetic Denervation on Symptoms and Cardiac Function in Patients With Heart Failure With Preserved Ejection Fraction.

TypeinterventionalSponsorRoyal Brompton & Harefield NHS Foundation TrustRan2013 to 2015Enrolled25ConditionsCardiac FailureArmsRenal sympathetic denervation
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. The denervation or activation of renal sympathetic nerve and renal blood flow.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2023
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Cardiac autonomic innervation.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Review
  8. Reconsidering Renal Sympathetic Denervation for Heart Failure.JACC. Basic to translational science · 2017
    Article
  9. Article
  10. Review
  11. Neurohormonal Blockade in Heart Failure.Cardiac failure review · 2017
    Article
  12. Review
  13. Article
  14. Review
  15. Renal denervation for resistant hypertension: yes.Internal and emergency medicine · 2016
    Article
  16. Cardio-renal syndrome.F1000Research · 2016
    Review
  17. Review
  18. Article
  19. Review
  20. Activation of afferent renal nerves modulates RVLM-projecting PVN neurons.American journal of physiology. Heart and circulatory physiology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 5 countries.

Paul A SobotkaMedtronic Inc., Santa Rosa, CA, USA. paul.a.sobotka@medtronic.com
Henry Krum
Michael Böhm
Darrel P Francis
Markus P Schlaich
Baker Heart and Diabetes Institute · AUMedtronic (Ireland) · IEMonash University · AUSt Mary's Hospital · GBUniversitätsklinikum des Saarlandes · DE

Funding

British Heart Foundation FS/10/38/28268
6 · The paper itself

Abstract

The heart and kidney interact in terms of hemodynamics and neurohumoral regulatory mechanisms, and this helps to maintain circulatory homeostasis under normal conditions. However, the normal regulatory mechanisms become inappropriate in the setting of congestive heart failure (CHF), and significant renal dysfunction often develops in CHF patients. Activation of renal sympathetic efferent nerves causes renin release, sodium and water retention, and reduced renal blood flow, all hallmarks of the renal manifestations of CHF. An increase in plasma levels of angiotensin II that is mediated in part by renal sympathetic activation has an effect on the central nervous system to further increase global sympathetic tone. Renal sympathetic activity can be assessed clinically by renal norepinephrine spillover, and an increase in renal norepinephrine spillover in CHF predicts reduced survival. In addition to efferent sympathetic activation, activation of renal sensory nerves in CHF may cause a reflex increase in sympathetic tone that contributes to elevated peripheral vascular resistance and vascular remodeling as well as left ventricular remodeling and dysfunction. In animal models of heart failure, surgical renal denervation has been shown to improve both renal and ventricular function. Although surgical renal denervation has long been known to lower blood pressure and improve survival in patients with hypertension, the invasive nature of this approach and its associated complications has limited its appeal. However, a novel catheter-based device has recently been introduced that specifically interrupts both efferent and afferent renal nerves, and there is significant interest in the use of this device to treat both hypertension and CHF. Several ongoing clinical trials are investigating the safety and efficacy of renal denervation in patients with CHF.

Indexed as

DenervationHeart FailureHumansKidneyNeurons, AfferentNeurons, EfferentNorepinephrineRenal CirculationSympathetic Nervous SystemNorepinephrine

Identifiers

PMID22392370
OpenAlexW2027853068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.